i-gel® from Intersurgical: clinical evidence listing

A comprehensive list of all known published clinical evidence on the device

Evaluation of i-gel(™) airway in children: a meta-analysis

Maitra S, Baidya DK, Bhattacharjee S, Khanna P. Paediatr Anaesth. 2014 Oct;24(10):1072-9

A total of nine studies were included using search keywords, with results finding that i-gel gave significantly higher leak pressure and ProSeal. Authors conclude it is an effective alternative to ProSeal and cLMA.

Link to abstract

Emergency airway management by paramedics: comparison between standard endotracheal intubation, laryngeal mask airway, and I-gel

Leventis C, Chalkias A, Sampanis MA, Foulidou X, Xanthos T. Eur J Emerg Med. 2014 Oct;21(5):371-3

72 briefly-trained paramedics were allocated to intubate a manikin. Success rate was higher, and insertion time 'significantly' shorter for the i-gel group.

Link to abstract

 

Comparison of i-gel™ and laryngeal mask airway in anesthetized paralyzed patients

Reza Hashemian SM, Nouraei N, Razavi SS, Zaker E, Jafari A, Eftekhari P, Radmand G, Mohajerani SA, Radpay B. Int J Crit Illn Inj Sci. 2014 Oct-Dec;4(4):288-92

64 patients assigned to either i-gel or cLMA groups in this randomised controlled trial. Results showed i-gel was 'significantly' quicker to insert.

Link to abstract

Randomized prospective trial comparing two supraglottic airway devices: i-gel™ and LMA-Supreme™ in paralyzed patients

Joly N, Poulin LP, Tanoubi I, Drolet P, Donati F, St-Pierre P. Can J Anaesth. 2014 Sep;61(9):794-800

100 patients were randomised between the two device groups, with 92% inserted successfully in both. i-gel recorded a shorter insertion time and higher incidence of complete vocal chord visualisation.

Link to abstract

About laryngeal mask: is the lowest price material the better cost-efficacy choice?

Weil G, Matysiak J, Guye ML, Eghiaian A, Bourgain JL. Ann Fr Anesth Reanim. 2014 Sep-Oct;33(9-10):508-13

Using LMA Unique as a reference, cost efficacy comparisons were made against i-gel, Ambu AuraOnce and LMA Supreme. Conclusions suggested that latest generation devices are still expensive despite low rate of complications.

Link to abstract